The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000460303
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
26/02/2026
Date registered
Help: Date registered
14/04/2026
Date last updated
Help: Date last updated
14/04/2026
Date data sharing statement initially provided
Help: Data sharing statement date
14/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
ECMO-RECOVERY: Evaluating a Recovery Intervention via a digital platform (app) to improve disability in adult patients after extracorporeal membrane oxygenation (ECMO)
Scientific title
ECMO-RECOVERY: A multicentre, randomised controlled trial evaluating a digitally supported recovery intervention to reduce disability at 6 months for adult survivors of extracorporeal membrane oxygenation (ECMO)
Additional trial identifiers [1] 316484 0
Monash University, ANZIC-RC/LH002
Universal Trial Number (UTN)
Trial acronym
ECMO-RECOVERY
Related trial records

Health condition
Health condition(s) studied:
Extracorporeal Membrane Oxygenation (ECMO) 340613 0
Cardiovascular or Lung diseases 341058 0
Condition category
Condition code
Cardiovascular 336805 336805 0 0
Other cardiovascular diseases
Respiratory 336806 336806 0 0
Other respiratory disorders / diseases

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Adult survivors of ECMO are recruited on the ward and randomised to the intervention or standard care group.

ECMO-RECOVERY intervention
The intervention encompasses virtual contact with a recovery coordinator through the digital platform (app) that includes

-Schedule of 9 virtual visits through video calling from the app (each visit approximately 30 minutes in duration)
-Ability to message the recovery coordinator
-Assistance with setting and monitoring goals during virtual visits
-Access to tailored educational resources on the app
The trial will offer a mix of educational resources developed by relevant peak bodies and bespoke resources developed for the trial. The Recovery Coordinator will assign resources based on the symptom profile of the participant as assessed during each virtual visit.
Pre-existing educational resources used are listed below:
1. My Life after ICU: https://www.mylifeaftericu.com/
2. VECMOS patient resources: https://www.vecmos.org.au/for-patients/
3. Nutrition resources (PDFs)
• Cooking for One, Food Fortification, Protein (Dietitian Connection)
• High Protein High Energy Diet (NEMO, Queensland Government, March 2024)
4. Heart failure and Exercise (PDF) – Dr Kate Hayes and Alfred Health
5. Life Lines (PDFs) Topics- Altered Sensation, Anxiety, Breathlessness, Cough, Difficulty sleeping, Dizziness, Fatigue, Flashbacks, Incontinence, Mood, Nausea, Nutrition, Swallowing, Voice change
6. Explain my procedure videos:
Topics- ECMO, Ventilation, Induced Coma, Delirium, Recovery after ICU, Swallowing, Voice change, Breathing Recovery, Nutrition
7. Guy’s and St Thomas’ resources:
• Critical care recovery website- https://www.criticalcarerecovery.com/
• Video- After having ECMO- Extracorporeal membrane oxygenation (ECMO) - After having ECMO | Guy's and St Thomas' NHS Foundation Trust
• PDFs- Voice care after ICU, Sleep hygiene, desensitization program
8. ICU Steps (PDF)- Physiotherapy and Recovery after ICU
9. ICU Digital pathway Patient videos
https://youtube.com/playlist?list=PLlEkbSroEPVdiwQmgHOJkiAspAAUXj3L2&si=wRDGlscf9jmIn8jM

-Tailored recommendations to support recovery, including feedback of recommendations to the patient's nominated GP, and
-Completion of patient-reported outcome measures (PROMs) via the app.
If required, the recovery coordinator will offer assistance with PROM completion.

The Recovery Coordinator will be a clinical staff member from the hospital where the patient underwent ECMO, e.g., a nurse or a physiotherapist. They will be trained to provide the intervention and equipped with an Operations manual that details the intervention. The digital platform (app) will be provided by Datos Health who will configure its Open Care platform for this trial. The e-platform will allow monitoring elements of intervention delivery via audit trails and logs. Trial monitoring in accordance with a monitoring plan will be undertaken to check protocol deviations and monitor adherence.
The Recovery Coordinators will be trained in trial procedures, trial protocol, including specific intervention components e.g., Goal setting. The training will be conducted through site visits and by the CPI and a specialist resource person to cover training on Goal setting and an online 1/2 day workshop 2 weeks before trial commencement. 

A process evaluation will be undertaken to evaluate the fidelity of the intervention through semi-structured interviews of patients, GPs and Recovery Coordinators, to understand the barriers and facilitators influencing implementation.
Intervention code [1] 333149 0
Treatment: Other
Description of the comparator or control
Patients in the control group will receive standard care as per usual in line with hospital post-discharge protocols and from their Primary Care Providers.. The Recovery Coordinator will follow up to collect PROMs if the patient has not completed them by the due date.

Standard Care offered to patients is variable and includes a discharge summary sent to GPs and some hospitals schedule a post-op follow-up around 6-8 weeks after discharge.
Patients are expected to follow up with their recommended allied health practitioners as advised during discharge and with their GP for ongoing care.
Control group
Active

Outcomes
Primary outcome [1] 344328 0
Disability at 6 months post-randomisation
Timepoint [1] 344328 0
Baseline, and at 6 months after randomisation
Secondary outcome [1] 457509 0
Change in disability from hospital discharge to 3 months
Timepoint [1] 457509 0
Baseline, and at 3 months after randomisation
Secondary outcome [2] 457510 0
Functional Independence at 3 and 6 months
Timepoint [2] 457510 0
At 3 and 6 months after randomisation
Secondary outcome [3] 457511 0
Health-related quality of life (HR-QoL)
Timepoint [3] 457511 0
Baseline, and at 3 and 6 months after randomisation
Secondary outcome [4] 457597 0
Mortality
Timepoint [4] 457597 0
At 3 and 6 months after randomisation
Secondary outcome [5] 457602 0
Anxiety and Depression
Timepoint [5] 457602 0
Baseline, and at 3 and 6 months after randomisation
Secondary outcome [6] 457603 0
Post-traumatic stress symptoms
Timepoint [6] 457603 0
Baseline, and at 3 and 6 months after randomisation
Secondary outcome [7] 457604 0
Cognitive function
Timepoint [7] 457604 0
Baseline, and at 6 months after randomisation
Secondary outcome [8] 457605 0
Patient Enablement
Timepoint [8] 457605 0
Baseline, and at 3 and 6 months after randomisation
Secondary outcome [9] 457611 0
Cost-effectiveness of intervention
Timepoint [9] 457611 0
6 months after randomisation

Eligibility
Key inclusion criteria
1. Patients who received ECMO in the ICU;
2. Age greater than or equal to 18 years;
3. Patients expected to survive to hospital discharge;
4. Patient enrolled in the EXCEL ECMO registry.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
1. Anticipated life expectancy <6 months due to a condition unrelated to ECMO;
2. Patient has a documented pre-existing medical diagnosis of cognitive impairment, e.g., dementia;
3. Unwilling and/or unable to use the website or app version of the e-platform;
4. Patient or Person responsible is unable to provide informed consent;
5. Patient not expected to reside in Australia for 6 months following randomisation;
6. Patient does not have a regular GP or is unable to identify or nominate a GP/primary care practice;
7. Patient received heart and/or lung transplant during their current admission;
8. Patient planned to receive mechanical circulatory support (e.g., ventricular assist device) post-hospital discharge;
9. Patient from Non-English-Speaking Background (NESB) with limited English proficiency that precludes communication with the recovery coordinator
10. Patients with a recovery navigator as part of routine clinical care or research study at the site that provides a similar intervention comprising virtual visits through video calling, goal setting, tailored resources, recommendations and feedback to GPs in addition to PROMs collection.

Study design
Purpose of the study
Educational / counselling / training
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Central randomisation by computer database.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
A permuted block randomisation method with variable block sizes stratified by site and ECMO mode (Veno-venous mode, Veno-arterial mode and Extracorporeal Cardiopulmonary Resuscitation) will be used to randomly allocate eligible participants to either standard care or intervention group in a 1:1 ratio. An independent statistician will formulate computer-driven, randomly allocated sequence generation.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Sample size calculation:
Based on data from the national EXCEL ECMO Registry, the standard deviation of the WHODAS 2.0 at 6 months is estimated at 22 per cent. A sample size of 206 patients provides 90% percent power to detect a 10-point difference in WHODAS 2.0 score between the intervention and control groups using a two-sided t-test with a 5% type-I error. This 10-point difference corresponds to the minimum clinically important difference previously validated in critically ill populations. To allow for potential loss to follow-up, withdrawal, or mortality, the total sample size has been inflated by 10 per cent, resulting in a proposed sample size of 227 patients.
This sample also provides over 80 per cent power to detect the same difference using a non-parametric Mann-Whitney U test (Guenther method), supporting the robustness of the estimate.

Statistical plan:
All variables will be summarised by treatment group as number (percentage) for categorical variables, and mean ± standard deviation (sd) or median (interquartile range) for continuous variables according to their distribution.
The primary endpoint will be presented as mean (sd) in each group and will be analysed using a linear model.
The model will be adjusted for prespecified prognosis factors:
• WHODAS 2.0 score at baseline
• Age
• ECMO mode (Veno-arterial, Veno-venous or Extracorporeal Cardiopulmonary Resuscitation)
• Severity of illness
A two-sided p-value of 0.05 will be used to indicate statistical significance.

Quantitative secondary endpoints will be analysed following the same methodology as the primary endpoint.
Binary endpoints will be presented as proportions of participants with the event in each group and will be analysed using a generalized linear regression with binomial distribution and log link function. Results will be presented as Risk ratios (RR) with 95% confidence intervals.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC
Recruitment hospital [1] 29116 0
Royal Prince Alfred Hospital - Camperdown
Recruitment hospital [2] 29118 0
St Vincent's Hospital (Darlinghurst) - Darlinghurst
Recruitment hospital [3] 29119 0
Gold Coast University Hospital - Southport
Recruitment hospital [4] 29120 0
The Prince Charles Hospital - Chermside
Recruitment hospital [5] 29121 0
Flinders Medical Centre - Bedford Park
Recruitment hospital [6] 29122 0
The Alfred - Melbourne
Recruitment hospital [7] 29124 0
Barwon Health - Geelong Hospital campus - Geelong
Recruitment postcode(s) [1] 45421 0
2050 - Camperdown
Recruitment postcode(s) [2] 45423 0
2010 - Darlinghurst
Recruitment postcode(s) [3] 45424 0
4215 - Southport
Recruitment postcode(s) [4] 45425 0
4032 - Chermside
Recruitment postcode(s) [5] 45426 0
5042 - Bedford Park
Recruitment postcode(s) [6] 45427 0
3004 - Melbourne
Recruitment postcode(s) [7] 45429 0
3220 - Geelong

Funding & Sponsors
Funding source category [1] 321095 0
Government body
Name [1] 321095 0
Medical Research Futures Fund (MRFF), Australian Government Department of Health, Disability and Ageing
Country [1] 321095 0
Australia
Primary sponsor type
University
Name
Monash University
Address
Country
Australia
Secondary sponsor category [1] 323964 0
None
Name [1] 323964 0
Address [1] 323964 0
Country [1] 323964 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319631 0
Alfred Hospital Ethics Committee
Ethics committee address [1] 319631 0
Ethics committee country [1] 319631 0
Australia
Date submitted for ethics approval [1] 319631 0
26/11/2025
Approval date [1] 319631 0
06/02/2026
Ethics approval number [1] 319631 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 147922 0
Dr Alisa Higgins
Address 147922 0
SPHPM, Monash University, 553 St Kilda Road, Melbourne, Victoria 3004
Country 147922 0
Australia
Phone 147922 0
+61400658694
Fax 147922 0
Email 147922 0
Contact person for public queries
Name 147923 0
Aruna Kartik
Address 147923 0
SPHPM, Monash University, 553 St Kilda Road, Melbourne, Victoria 3004
Country 147923 0
Australia
Phone 147923 0
+61422202412
Fax 147923 0
Email 147923 0
Contact person for scientific queries
Name 147924 0
Dr Alisa Higgins
Address 147924 0
SPHPM, Monash University, 553 St Kilda Road, Melbourne, Victoria 3004
Country 147924 0
Australia
Phone 147924 0
+61400658694
Fax 147924 0
Email 147924 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.